O4‐11‐04: ACTIVE Aβ IMMUNOTHERAPY CAD106 PHASE II DOSE‐ADJUVANT FINDING STUDY: SAFETY AND CNS BIOMARKERS. (1st July 2014) - Graf, Ana; Riviere, Marie‐Emmanuelle; Caputo, Angelika; Farlow, Martin Rhys; Marotta, Giovanni; Sanchez‐Valle, Raquel; Scheltens, Philip; Ryan, J. Michael; Vandenberghe, Rik R.